USA Insomnia Therapy Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Insomnia Therapy Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Non-pharmacological Therapy Market Performance (Volume)
  • 2.1.2 Pharmacological Therapy Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Non-pharmacological Therapy Market Performance (Value)
  • 2.1.2 Pharmacological Therapy Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospital Market Performance (Volume)
  • 3.1.2 Ambulatory Surgical Center Market Performance (Volume)
  • 3.1.3 Home Care Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Merck & Co. Inc.
  • 4.1.1 Merck & Co. Inc. Profiles
  • 4.1.2 Merck & Co. Inc. Product Information
  • 4.1.3 Merck & Co. Inc. Insomnia Therapy Business Performance
  • 4.1.4 Merck & Co. Inc. Insomnia Therapy Business Development and Market Status
• 4.2 Sanofi
  • 4.2.1 Sanofi Profiles
  • 4.2.2 Sanofi Product Information
  • 4.2.3 Sanofi Insomnia Therapy Business Performance
  • 4.2.4 Sanofi Insomnia Therapy Business Development and Market Status
• 4.3 Pfizer, Inc.
  • 4.3.1 Pfizer, Inc. Profiles
  • 4.3.2 Pfizer, Inc. Product Information
  • 4.3.3 Pfizer, Inc. Insomnia Therapy Business Performance
  • 4.3.4 Pfizer, Inc. Insomnia Therapy Business Development and Market Status
• 4.4 Takeda Pharmaceutical Company Ltd.
  • 4.4.1 Takeda Pharmaceutical Company Ltd. Profiles
  • 4.4.2 Takeda Pharmaceutical Company Ltd. Product Information
  • 4.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Business Performance
  • 4.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Business Development and Market Status
• 4.5 Purdue Pharmaceuticals L.P.
  • 4.5.1 Purdue Pharmaceuticals L.P. Profiles
  • 4.5.2 Purdue Pharmaceuticals L.P. Product Information
  • 4.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Business Performance
  • 4.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Business Development and Market Status
• 4.6 Eisai, Co. Ltd.
  • 4.6.1 Eisai, Co. Ltd. Profiles
  • 4.6.2 Eisai, Co. Ltd. Product Information
  • 4.6.3 Eisai, Co. Ltd. Insomnia Therapy Business Performance
  • 4.6.4 Eisai, Co. Ltd. Insomnia Therapy Business Development and Market Status
• 4.7 Meda Consumer Healthcare Inc.
  • 4.7.1 Meda Consumer Healthcare Inc. Profiles
  • 4.7.2 Meda Consumer Healthcare Inc. Product Information
  • 4.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Business Performance
  • 4.7.4 Meda Consumer Healthcare Inc. Insomnia Therapy Business Development and Market Status
• 4.8 Pernix Therapeutics
  • 4.8.1 Pernix Therapeutics Profiles
  • 4.8.2 Pernix Therapeutics Product Information
  • 4.8.3 Pernix Therapeutics Insomnia Therapy Business Performance
  • 4.8.4 Pernix Therapeutics Insomnia Therapy Business Development and Market Status
• 4.9 Vanda Pharmaceuticals
  • 4.9.1 Vanda Pharmaceuticals Profiles
  • 4.9.2 Vanda Pharmaceuticals Product Information
  • 4.9.3 Vanda Pharmaceuticals Insomnia Therapy Business Performance
  • 4.9.4 Vanda Pharmaceuticals Insomnia Therapy Business Development and Market Status
• 4.10 ECR Pharmaceuticals
  • 4.10.1 ECR Pharmaceuticals Profiles
  • 4.10.2 ECR Pharmaceuticals Product Information
  • 4.10.3 ECR Pharmaceuticals Insomnia Therapy Business Performance
  • 4.10.4 ECR Pharmaceuticals Insomnia Therapy Business Development and Market Status
• 4.11 Fidia Farmaceutici
• 4.12 Dainippon Sumitomo
• 4.13 Pfizer, Inc.
• 4.14 Takeda Pharmaceutical Company Ltd.
• 4.15 Purdue Pharmaceuticals L.P.

5 Market Performance for Manufacturers

• 5.1 USA Insomnia Therapy Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 USA Insomnia Therapy Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 USA Insomnia Therapy Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 USA Insomnia Therapy Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Insomnia Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Northeast Insomnia Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Northeast Insomnia Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Northeast Insomnia Therapy Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Insomnia Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Midwest Insomnia Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Midwest Insomnia Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Midwest Insomnia Therapy Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Insomnia Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Insomnia Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Insomnia Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Insomnia Therapy Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Insomnia Therapy Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 West Insomnia Therapy Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 West Insomnia Therapy Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 West Insomnia Therapy Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration

7 USA Insomnia Therapy Market Performance (Sales Point)

• 7.1 USA Insomnia Therapy Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 USA Insomnia Therapy Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 USA Insomnia Therapy Price (USD/Unit) by Regions 2013-2018
• 7.4 USA Insomnia Therapy Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 USA Insomnia Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Northeast Insomnia Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Midwest Insomnia Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Insomnia Therapy Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 West Insomnia Therapy Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospital Industry
• 11.2 Ambulatory Surgical Center Industry
• 11.3 Home Care Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 USA Insomnia Therapy Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 USA Insomnia Therapy Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Northeast Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Midwest Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 West Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Insomnia Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Non-pharmacological Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Pharmacological Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospital Sales and and Growth Rate 2019-2024
  • 12.4.3 Ambulatory Surgical Center Sales and and Growth Rate 2019-2024
  • 12.4.4 Home Care Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Insomnia Therapy Price (USD/Unit) Trend 2019-2024
  • 12.5.2 USA Insomnia Therapy Gross Profit Trend 2019-2024

13 Conclusion